Aptean provides COVID-19 Researchers free access to sequencing software
25 March 2020
Aptean has announced that it will share tools with the scientific community to help their efforts in researching and responding to the current COVID-19 pandemic
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
